Cargando…

TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis

Inherited and acquired mutations in hematopoietic stem cells can cause clonal expansion with increased risk of cardiovascular disease (CVD), a condition known for the clonal hematopoiesis of indeterminate potential (CHIP). Inherited genetic variants in two CHIP-associated genome loci, the telomerase...

Descripción completa

Detalles Bibliográficos
Autores principales: Opstad, Trine B., Solheim, Svein, Pettersen, Alf-Åge R., Kalstad, Are A., Arnesen, Harald, Seljeflot, Ingebjørg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406025/
https://www.ncbi.nlm.nih.gov/pubmed/36009574
http://dx.doi.org/10.3390/biomedicines10082027
_version_ 1784774022717767680
author Opstad, Trine B.
Solheim, Svein
Pettersen, Alf-Åge R.
Kalstad, Are A.
Arnesen, Harald
Seljeflot, Ingebjørg
author_facet Opstad, Trine B.
Solheim, Svein
Pettersen, Alf-Åge R.
Kalstad, Are A.
Arnesen, Harald
Seljeflot, Ingebjørg
author_sort Opstad, Trine B.
collection PubMed
description Inherited and acquired mutations in hematopoietic stem cells can cause clonal expansion with increased risk of cardiovascular disease (CVD), a condition known for the clonal hematopoiesis of indeterminate potential (CHIP). Inherited genetic variants in two CHIP-associated genome loci, the telomerase gene telomerase enzyme reverse transcriptase (TERT) (rs7705526) and the epigenetic regulator ten–eleven translocation 2 (TET2) (rs2454206), were investigated in 1001 patients with stable coronary artery disease (CAD) (mean age 62 years, 22% women), with regards to cardiovascular outcome, comorbidities, and leukocyte telomere length. Over 2 years, mutated TERT increased the risk two-fold for major clinical events (MACEs) in all patients (p = 0.004), acute myocardial infarction (AMI) in male patients (p = 0.011), and stroke in female patients (p < 0.001). Mutated TET2 correlated with type 2 diabetes (p < 0.001), the metabolic syndrome (p = 0.002), as well as fasting glucose, HbA1c, and shorter telomeres (p = 0.032, p = 0.003, and p = 0.016, respectively). In conclusion, our results from stable CAD patients highlight TERTs’ role in CVD, and underline TET2s’ role in the epigenetic regulation of lifestyle-related diseases.
format Online
Article
Text
id pubmed-9406025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94060252022-08-26 TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis Opstad, Trine B. Solheim, Svein Pettersen, Alf-Åge R. Kalstad, Are A. Arnesen, Harald Seljeflot, Ingebjørg Biomedicines Article Inherited and acquired mutations in hematopoietic stem cells can cause clonal expansion with increased risk of cardiovascular disease (CVD), a condition known for the clonal hematopoiesis of indeterminate potential (CHIP). Inherited genetic variants in two CHIP-associated genome loci, the telomerase gene telomerase enzyme reverse transcriptase (TERT) (rs7705526) and the epigenetic regulator ten–eleven translocation 2 (TET2) (rs2454206), were investigated in 1001 patients with stable coronary artery disease (CAD) (mean age 62 years, 22% women), with regards to cardiovascular outcome, comorbidities, and leukocyte telomere length. Over 2 years, mutated TERT increased the risk two-fold for major clinical events (MACEs) in all patients (p = 0.004), acute myocardial infarction (AMI) in male patients (p = 0.011), and stroke in female patients (p < 0.001). Mutated TET2 correlated with type 2 diabetes (p < 0.001), the metabolic syndrome (p = 0.002), as well as fasting glucose, HbA1c, and shorter telomeres (p = 0.032, p = 0.003, and p = 0.016, respectively). In conclusion, our results from stable CAD patients highlight TERTs’ role in CVD, and underline TET2s’ role in the epigenetic regulation of lifestyle-related diseases. MDPI 2022-08-19 /pmc/articles/PMC9406025/ /pubmed/36009574 http://dx.doi.org/10.3390/biomedicines10082027 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Opstad, Trine B.
Solheim, Svein
Pettersen, Alf-Åge R.
Kalstad, Are A.
Arnesen, Harald
Seljeflot, Ingebjørg
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title_full TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title_fullStr TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title_full_unstemmed TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title_short TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
title_sort tert and tet2 genetic variants affect leukocyte telomere length and clinical outcome in coronary artery disease patients—a possible link to clonal hematopoiesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406025/
https://www.ncbi.nlm.nih.gov/pubmed/36009574
http://dx.doi.org/10.3390/biomedicines10082027
work_keys_str_mv AT opstadtrineb tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis
AT solheimsvein tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis
AT pettersenalfager tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis
AT kalstadarea tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis
AT arnesenharald tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis
AT seljeflotingebjørg tertandtet2geneticvariantsaffectleukocytetelomerelengthandclinicaloutcomeincoronaryarterydiseasepatientsapossiblelinktoclonalhematopoiesis